Current trends in West Nile virus vaccine development

Matrix-M™ adjuvanted envelope protein vaccine protects against lethal lineage 1 and 2 West Nile virus infection in mice

(2014) Sofia E. Magnusson et al.   VACCINE

West Nile virus and kidney disease

(2013) Luisa Barzon et al.   Expert Review of Anti-Infective Therapy

West Nile Virus: Review of the Literature

(2013) Lyle R. Petersen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Temporal Dynamics of the Primary Human T Cell Response to Yellow Fever Virus 17D As It Matures from an Effector- to a Memory-Type Response

(2013) K. Blom et al.   JOURNAL OF IMMUNOLOGY

Excretion of West Nile Virus in Urine During Acute Infection

(2013) Luisa Barzon et al.   JOURNAL OF INFECTIOUS DISEASES

Yellow Fever Vaccination Elicits Broad Functional CD4+T Cell Responses That Recognize Structural and Nonstructural Proteins

(2013) Eddie A. James et al.   JOURNAL OF VIROLOGY

Vaccination of Captive Nēnē (Branta sandvicensis) against West Nile Virus Using a Protein-based Vaccine (WN-80E)

(2013) Susan I. Jarvi et al.   JOURNAL OF WILDLIFE DISEASES

West Nile virus infection and immunity

(2013) Mehul S. Suthar et al.   NATURE REVIEWS MICROBIOLOGY

Next Generation Inactivated Polio Vaccine Manufacturing to Support Post Polio-Eradication Biosafety Goals

(2013) Yvonne E. Thomassen et al.   PLoS One

The live attenuated chimeric vaccine rWN/DEN4Δ30 is well-tolerated and immunogenic in healthy flavivirus-naïve adult volunteers

(2013) Anna P. Durbin et al.   VACCINE

Inactivated West Nile Virus (WNV) vaccine, Duvaxyn WNV, protects against a highly neuroinvasive lineage 2 WNV strain in mice

(2013) Marietjie Venter et al.   VACCINE

Long-term safety assessment of live attenuated tetravalent dengue vaccines: Deliberations from a WHO technical consultation

(2013) Adwoa D. Bentsi-Enchill et al.   VACCINE

A novel platform for virus-like particle-display of flaviviral envelope domain III: induction of Dengue and West Nile virus neutralizing antibodies

(2013) Anthony JS Chua et al.   Virology Journal

CD8 and CD4 T Cells in West Nile Virus Immunity and Pathogenesis

(2013) Jason Netland et al.   Viruses-Basel

Preclinical and Clinical Development of a YFV 17 D-Based Chimeric Vaccine against West Nile Virus

(2013) Gustavo Dayan et al.   Viruses-Basel

West Nile Virus in the United States — A Historical Perspective

(2013) John Roehrig   Viruses-Basel

The Changing Epidemiology of Kunjin Virus in Australia

(2013) Natalie Prow   International Journal of Environmental Research and Public Health

A Hamster-Derived West Nile Virus Isolate Induces Persistent Renal Infection in Mice

(2013) Vandana Saxena et al.   PLoS Neglected Tropical Diseases

A humanized IgG but not IgM antibody is effective in prophylaxis and therapy of yellow fever infection in an AG129/17D-204 peripheral challenge mouse model

(2012) Brett A. Thibodeaux et al.   ANTIVIRAL RESEARCH

Estimated cumulative incidence of West Nile virus infection in US adults, 1999–2010

(2012) L. R. PETERSEN et al.   EPIDEMIOLOGY AND INFECTION

The future of human DNA vaccines

(2012) Lei Li et al.   JOURNAL OF BIOTECHNOLOGY

Measles Vaccine Expressing the Secreted Form of West Nile Virus Envelope Glycoprotein Induces Protective Immunity in Squirrel Monkeys, a New Model of West Nile Virus Infection

(2012) Samantha Brandler et al.   JOURNAL OF INFECTIOUS DISEASES

A Hydrogen Peroxide-Inactivated Virus Vaccine Elicits Humoral and Cellular Immunity and Protects against Lethal West Nile Virus Infection in Aged Mice

(2012) A. K. Pinto et al.   JOURNAL OF VIROLOGY

Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial

(2012) Arunee Sabchareon et al.   LANCET

Development of a new hydrogen peroxide–based vaccine platform

(2012) Ian J Amanna et al.   NATURE MEDICINE

Prevalence of Chronic Kidney Disease and Progression of Disease Over Time among Patients Enrolled in the Houston West Nile Virus Cohort

(2012) Melissa S. Nolan et al.   PLoS One

Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions

(2012) R. de Alwis et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Outbreak Pattern Stymies Vaccine Work

(2012) J. Kaiser   SCIENCE

Phase II, dose ranging study of the safety and immunogenicity of single dose West Nile vaccine in healthy adults ≥50 years of age

(2012) Gustavo H. Dayan et al.   VACCINE

Flaviviruses and flavivirus vaccines

(2012) Franz X. Heinz et al.   VACCINE

Licensure of vaccines using the Animal Rule

(2012) Drusilla L Burns   Current Opinion in Virology

Electroporation delivery of DNA vaccines: prospects for success

(2011) Niranjan Y Sardesai et al.   CURRENT OPINION IN IMMUNOLOGY

Critical issues in dengue vaccine development

(2011) Stephen J. Thomas et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Completeness of West Nile virus testing in patients with meningitis and encephalitis during an outbreak in Arizona, USA

(2011) I. B. WEBER et al.   EPIDEMIOLOGY AND INFECTION

A Tick-borne Encephalitis Virus Vaccine Based on the European Prototype Strain Induces Broadly Reactive Cross-neutralizing Antibodies in Humans

(2011) Klaus K. Orlinger et al.   JOURNAL OF INFECTIOUS DISEASES

A West Nile Virus DNA Vaccine Utilizing a Modified Promoter Induces Neutralizing Antibody in Younger and Older Healthy Adults in a Phase I Clinical Trial

(2011) Julie E. Ledgerwood et al.   JOURNAL OF INFECTIOUS DISEASES

Microarray hybridization for assessment of the genetic stability of chimeric west nile/dengue 4 virus

(2011) Majid Laassri et al.   JOURNAL OF MEDICAL VIROLOGY

Poorly Neutralizing Cross-Reactive Antibodies against the Fusion Loop of West Nile Virus Envelope Protein Protect In Vivo via Fc  Receptor and Complement-Dependent Effector Mechanisms

(2011) M. R. Vogt et al.   JOURNAL OF VIROLOGY

Protection provided by a recombinant ALVAC®-WNV vaccine expressing the prM/E genes of a lineage 1 strain of WNV against a virulent challenge with a lineage 2 strain

(2011) J.M. Minke et al.   VACCINE

Evaluation of a virosomal H5N1 vaccine formulated with Matrix M™ adjuvant in a phase I clinical trial

(2011) Rebecca J. Cox et al.   VACCINE

Delayed Mortality in a Cohort of Persons Hospitalized with West Nile Virus Disease in Colorado in 2003

(2011) Nicole P. Lindsey et al.   VECTOR-BORNE AND ZOONOTIC DISEASES

Evaluation of RepliVAX WN, a Single-Cycle Flavivirus Vaccine, in a Non-Human Primate Model of West Nile Virus Infection

(2010) Douglas G. Widman et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Chimeric vaccine composed of viral peptide and mammalian heat-shock protein 60 peptide protects against West Nile virus challenge

(2010) Orly Gershoni-Yahalom et al.   IMMUNOLOGY

TLR9-Targeted Biodegradable Nanoparticles as Immunization Vectors Protect against West Nile Encephalitis

(2010) S. L. Demento et al.   JOURNAL OF IMMUNOLOGY

West Nile Virus RNA Not Detected in Urine of 40 People Tested 6 Years After Acute West Nile Virus Disease

(2010) K. B. Gibney et al.   JOURNAL OF INFECTIOUS DISEASES

West Nile Fever Characteristics among Viremic Persons Identified through Blood Donor Screening

(2010) Shimian Zou et al.   JOURNAL OF INFECTIOUS DISEASES

Phase II, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Investigate the Immunogenicity and Safety of a West Nile Virus Vaccine in Healthy Adults

(2010) Rex Biedenbender et al.   JOURNAL OF INFECTIOUS DISEASES

Phylogeography of West Nile Virus: from the Cradle of Evolution in Africa to Eurasia, Australia, and the Americas

(2010) F. J. May et al.   JOURNAL OF VIROLOGY

Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes

(2010) Scott B Halstead et al.   LANCET INFECTIOUS DISEASES

An inactivated West Nile Virus vaccine derived from a chemically synthesized cDNA system

(2010) Klaus K. Orlinger et al.   VACCINE

A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice

(2010) Gunther Spohn et al.   Virology Journal

Wanted, dead or alive: New viral vaccines

(2009) Ian J. Amanna et al.   ANTIVIRAL RESEARCH

Immunogenicity and Protective Efficacy of a Recombinant Subunit West Nile Virus Vaccine in Rhesus Monkeys

(2009) M. M. Lieberman et al.   Clinical and Vaccine Immunology

The host immunologic response to West Nile encephalitis virus

(2009) Michael et al.   Frontiers in Bioscience-Landmark

The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD8+ T Cell Response

(2009) R. S. Akondy et al.   JOURNAL OF IMMUNOLOGY

Persistent Infection with West Nile Virus Years after Initial Infection

(2009) Kristy Murray et al.   JOURNAL OF INFECTIOUS DISEASES

Human Monoclonal Antibodies against West Nile Virus Induced by Natural Infection Neutralize at a Postattachment Step

(2009) M. R. Vogt et al.   JOURNAL OF VIROLOGY

Coimmunization with an optimized IL15 plasmid adjuvant enhances humoral immunity via stimulating B cells induced by genetically engineered DNA vaccines expressing consensus JEV and WNV E DIII

(2009) Mathura P. Ramanathan et al.   VACCINE

Development and characterization of non-glycosylated E and NS1 mutant viruses as a potential candidate vaccine for West Nile virus

(2009) Melissa C. Whiteman et al.   VACCINE

Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses

(2009) Bruno Guy et al.   VACCINE

The Zoonotic Flaviviruses of Southern, South-Eastern and Eastern Asia, and Australasia: The Potential for Emergent Viruses

(2009) J. S. Mackenzie et al.   Zoonoses and Public Health

Human Effector and Memory CD8+ T Cell Responses to Smallpox and Yellow Fever Vaccines

(2008) Joseph D. Miller et al.   IMMUNITY

The structural immunology of antibody protection against West Nile virus

(2008) Michael S. Diamond et al.   IMMUNOLOGICAL REVIEWS

Effects of West Nile Virus May Persist

(2008) Rebecca Voelker   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Single-round infectious particles enhance immunogenicity of a DNA vaccine against West Nile virus

(2008) David C Chang et al.   NATURE BIOTECHNOLOGY

Protective Antiviral Immunity Conferred by a Nonintegrative Lentiviral Vector-Based Vaccine

(2008) Frédéric Coutant et al.   PLoS One

Construction and characterization of a second-generation pseudoinfectious West Nile virus vaccine propagated using a new cultivation system

(2008) Douglas G. Widman et al.   VACCINE

Attenuated West Nile viruses bearing 3′SL and envelope gene substitution mutations

(2008) Li Yu et al.   VACCINE

The relative contribution of antibody and CD8+ T cells to vaccine immunity against West Nile encephalitis virus

(2008) Bimmi Shrestha et al.   VACCINE

Recombinant vesicular stomatitis virus-based west Nile vaccine elicits strong humoral and cellular immune responses and protects mice against lethal challenge with the virulent west Nile virus strain LSU-AR01

(2008) Arun V. Iyer et al.   VACCINE

Vero cell-derived inactivated West Nile (WN) vaccine induces protective immunity against lethal WN virus infection in mice and shows a facilitated neutralizing antibody response in mice previously immunized with Japanese encephalitis vaccine

(2008) Chang-Kweng Lim et al.   VIROLOGY

Maturation of West Nile Virus Modulates Sensitivity to Antibody-Mediated Neutralization

(2008) Steevenson Nelson et al.   PLoS Pathogens

A Global Perspective on the Epidemiology of West Nile Virus

(2007) Laura D. Kramer et al.   Annual Review of Entomology